Objetivo
Infections caused by antimicrobial-resistant bacteria (AMRB) account for an increasing proportion of healthcare-associated infections, particularly in high-risk units such as intensive care units and surgery; patients discharged to rehabilitation units often remain carriers of AMRB, contributing to their dissemination into longer-term care areas and within the community.
The overall objective of MOSAR is to gain breakthrough knowledge in the dynamics of transmission of AMRB, and address highly controversial issues by testing strategies to combat the emergence and spread of antimicrobial resistance, focusing on the major and emerging multi-drug antimicrobial resistant microorganisms in hospitals, now spreading into the community. Microbial genomics and human response to carriage of AMRB will be integrated with health sciences research, including interventional controlled studies in diverse hospital settings, mathematical modelling of resistance dynamics, and health economics.
Ámbito científico
- medical and health sciencesclinical medicinephysiotherapy
- medical and health scienceshealth sciences
- medical and health sciencesclinical medicinecritical care medicine
- social scienceseconomics and businesseconomicshealth economics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Convocatoria de propuestas
FP6-2005-LIFESCIHEALTH-6
Consulte otros proyectos de esta convocatoria
Régimen de financiación
IP - Integrated ProjectCoordinador
PARIS
Francia
Ver en el mapa
Participantes (16)
85500 UTRECHT
Ver en el mapa
TEL AVIV
Ver en el mapa
LONDON
Ver en el mapa
CRETEIL
Ver en el mapa
105 LE CHESNAY
Ver en el mapa
CHILLY MAZARIN
Ver en el mapa
CARDIFF
Ver en el mapa
HAMBURG
Ver en el mapa